Literature DB >> 2861254

Controlled induction of paired helical filaments of the Alzheimer type in cultured human neurons, by glutamate and aspartate.

U De Boni, D R McLachlan.   

Abstract

One characteristic histopathological feature of brains of patients with Senile Dementia of the Alzheimer Type (SDAT) is a neuronal change known as neurofibrillary degeneration. Ultrastructurally, this degeneration presents as aggregates of Paired Helical Filaments (PHFs). We have reported (De Boni and Crapper 1978) that brain affected with SDAT contains a factor which induces PHFs similar to those occurring in Alzheimer's disease, in human CNS neurons in vitro. We now report that PHFs may be induced in cultured, fetal human spinal cord lesions by factors other than extracts from brain affected by SDAT. Specifically, ultrastructural analyses have shown that PHFs closely similar to those found in SDAT are induced by the excitotoxic aminoacids, glutamate (Glu) and aspartate (Asp). PHFs were found with Glu and Asp in combination at 1.1 and 0.45 mM, respectively and by Glu alone at 2.2 mM, when added to the culture medium. Cultures grown and maintained in MEM Eagle medium without Glu and Asp were invariably composed of tightly packed neuropil with abundant synaptic contacts, were free of vacuolated somata or processes and did not exhibit the presence of PHFs. In contrast, cultures exposed to Glu and Asp invariably responded with the presence of vacuolated neuronal somata and degenerating neuronal processes containing intermediate filaments, frequently paired into PHFs. These induced PHFs are composed of intermediate filaments morphologically identical (diameter 10 +/- 0.9 nm, n = 55) to neurofilaments. While the induced PHFs exhibit a range of periodicities (50-540 nm) with an overall mean period of 140 +/- 68 nm (n = 245), approximately 4% are morphologically closely similar (mean period 76 +/- 10 nm, n = 10) to those in SDAT.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2861254     DOI: 10.1016/0022-510x(85)90093-0

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  11 in total

Review 1.  The molecular mechanisms of scrapie encephalopathy and relevance to human neurodegenerative disease.

Authors:  W J Lukiw; H J Cho; J C Kaufmann; D R Crapper McLachlan
Journal:  Can J Vet Res       Date:  1990-01       Impact factor: 1.310

2.  Enhanced neuronal regeneration by retinoic acid of murine dorsal root ganglia and of fetal murine and human spinal cord in vitro.

Authors:  S D Quinn; U De Boni
Journal:  In Vitro Cell Dev Biol       Date:  1991-01

3.  Diltiazem-induced neuroprotection in glutamate excitotoxicity and ischemic insult of retinal neurons.

Authors:  Géraldine Vallazza-Deschamps; Céline Fuchs; David Cia; Luc-Henri Tessier; José A A Sahel; Henri Dreyfus; Serge Picaud
Journal:  Doc Ophthalmol       Date:  2005-01       Impact factor: 2.379

4.  Expression in cultured human neuroblastoma cells of epitopes associated with affected neurons in Alzheimer's disease.

Authors:  L W Ko; K F Sheu; O Young; H Thaler; J P Blass
Journal:  Am J Pathol       Date:  1990-04       Impact factor: 4.307

5.  Induction of epitopes associated with neurofibrillary tangles in clonal mouse neuroblastoma (S20Y) cells.

Authors:  L Ko; K F Sheu; O Young; J P Blass
Journal:  Acta Neuropathol       Date:  1990       Impact factor: 17.088

6.  Excitotoxicity in the lung: N-methyl-D-aspartate-induced, nitric oxide-dependent, pulmonary edema is attenuated by vasoactive intestinal peptide and by inhibitors of poly(ADP-ribose) polymerase.

Authors:  S I Said; H I Berisha; H Pakbaz
Journal:  Proc Natl Acad Sci U S A       Date:  1996-05-14       Impact factor: 11.205

7.  Reduction of posttraumatic transneuronal "early gene" activation and dendritic atrophy by the N-methyl-D-aspartate receptor antagonist MK-801.

Authors:  R Nitsch; M Frotscher
Journal:  Proc Natl Acad Sci U S A       Date:  1992-06-01       Impact factor: 11.205

8.  Detection of glutamine synthetase in the cerebrospinal fluid of Alzheimer diseased patients: a potential diagnostic biochemical marker.

Authors:  D Gunnersen; B Haley
Journal:  Proc Natl Acad Sci U S A       Date:  1992-12-15       Impact factor: 11.205

9.  Pharmacological models in Alzheimer's disease research.

Authors:  C Gilles; S Ertlé
Journal:  Dialogues Clin Neurosci       Date:  2000-09       Impact factor: 5.986

10.  Intracellular fibril formation, calcification, and enrichment of chaperones, cytoskeletal, and intermediate filament proteins in the adult hippocampus CA1 following neonatal exposure to the nonprotein amino acid BMAA.

Authors:  Oskar Karlsson; Anna-Lena Berg; Jörg Hanrieder; Gunnel Arnerup; Anna-Karin Lindström; Eva B Brittebo
Journal:  Arch Toxicol       Date:  2014-05-06       Impact factor: 5.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.